APExBIO Technology
APExBIO Technology is a Houston-based life sciences reagent supplier founded in 2013, selling bioactive compounds, mRNA synthesis products, assay kits, and bioreagents via direct e-commerce (apexbt.com) and VWR distribution to academic, pharmaceutical, and biotechnology researchers globally.
- Company typePrivate
- Founded2013
- HeadquartersHouston, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What APExBIO Technology does
APExBIO Technology (ApexBio Technology, DBA APExBIO) is a Houston, Texas-based life sciences reagent supplier founded in 2013, operating as a private company with 51-100 employees. The company sells bioactive compounds (enzyme inhibitors, signaling pathway modulators, screening libraries, fluorescent dyes, natural products, peptides, ADC linkers, PROTACs, and isotope-labeled compounds), RNA research solutions (IVT reagents, cap analogs, modified nucleotides, reporter gene mRNAs, disease/immune mRNAs, gene editing mRNAs, circular RNA, self-amplifying RNA, and custom RNA synthesis), recombinant proteins and antibodies, bioreagents (cell culture, molecular biology kits, organoid culture, enzymes), and ready-to-use assay kits (Caspase kits, Annexin V kits, DNA ladder detection kits, CCK-8). Underlying technology includes in vitro transcription (IVT) for mRNA synthesis with cap analog incorporation and poly(A) tailing, plus proprietary reagents such as Tyramide Signal Amplification (TSA) and Phos Binding Reagents that enable protein phosphorylation analysis without phospho-specific antibodies. Products target apoptosis, kinase, GPCR, epigenetics, metabolism, cell cycle, immunology, and neuroscience research pathways, with catalog items priced from roughly $30 to $1,477 and assay kits shipping within 5-10 days. The company also offers custom synthesis services for compound libraries, proteins, and mRNA products.
APExBIO serves academic research institutions, pharmaceutical companies, and biotechnology firms globally. Its go-to-market is primarily direct-to-consumer e-commerce through apexbt.com, supplemented by a distribution partnership with VWR International (which offers promotional free-sample incentives). Marketing relies on scientific content marketing (the company displays 30+ peer-reviewed publication covers citing its products on its homepage), an email newsletter, and the VWR channel. The company is led by founder and CEO Shailja Dixit. Revenue is generated through one-time product sales via the e-commerce storefront, wholesale through VWR, and custom synthesis professional services. The company has operated continuously since 2013 without disclosed outside funding, and no patents, M&A activity, or institutional ownership are documented in the available source material.
APExBIO Technology firmographics
Firmographics- Name
- APExBIO Technology
- Legal name
- ApexBio Technology
- Website
- https://apexbt.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- APExBIO Technology is a Houston-based life sciences reagent supplier founded in 2013, selling bioactive compounds, mRNA synthesis products, assay kits, and bioreagents via direct e-commerce (apexbt.com) and VWR distribution to academic, pharmaceutical, and biotechnology researchers globally.
- Ownership category
- akta.pro rank
APExBIO Technology industry classification
Industry- Product category
- Life Sciences Research Reagents
- NAICS
- Medicinal and Botanical Manufacturing (325411), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)
- akta.pro secondary industries
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD), Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)
Keywords
Where APExBIO Technology is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
APExBIO Technology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Product Sales (E-commerce): Direct sales of bioactive compounds, assay kits, mRNA products, bioreagents, and laboratory reagents through the company's e-commerce platform. Products are sold in catalog sizes with unit pricing based on quantity and formulation.
- Custom Synthesis Services: Custom synthesis services for compounds, proteins, and mRNA products tailored to specific research requirements of pharmaceutical and biotechnology customers.
- Distributor Sales: Sales through distribution partners including VWR, generating revenue from wholesale purchases by laboratory supply distributors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Assay Kits - Caspase-12 Fluorometric Assay Kit |
| Unit Pricing | Pay-as-you-go | Assay Kits - Enhanced Apoptotic DNA Ladder Detection Kit |
| Unit Pricing | Pay-as-you-go | Assay Kits - Annexin V-PE Apoptosis Detection Kit |
| Unit Pricing | Pay-as-you-go | Bioactive Compounds - INCB024360 analogue |
| Unit Pricing | Pay-as-you-go | Bioactive Compounds - Inauhzin (SIRT1 inhibitor) |
| Unit Pricing | Pay-as-you-go | Bioactive Compounds - Imatinib Mesylate |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
APExBIO Technology product offering
Product offeringCore offering
APExBIO Technology manufactures and distributes life sciences research biochemicals, including bioactive compounds (signaling pathway inhibitors, screening libraries, fluorescent dyes, PROTACs, ADC linkers, peptides), RNA research solutions (mRNA synthesis products, IVT reagents, cap analogs, reporter gene mRNAs), recombinant proteins and antibodies, assay kits, molecular biology kits, and bioreagents. The company also offers custom synthesis services for compound libraries, proteins, and RNA tailored to specific research requirements.
Product overview
APExBIO Technology is a biochemical research products company offering a comprehensive portfolio of bioactive compounds, RNA research solutions, recombinant proteins and antibodies, and bioreagents. The product line includes enzyme inhibitors targeting signaling pathways (apoptosis, kinases, GPCRs, epigenetics), mRNA synthesis products and custom RNA services, protein assay kits, cell-based assays, molecular biology kits, and custom synthesis services. The company serves the life science research market with products for drug discovery, cancer research, immunology, and cell biology applications.
Differentiator
Problem solved
Functional benefit
Products and services
- Bioactive Compounds Comprehensive catalog of bioactive compounds including enzyme inhibitors, signaling pathway modulators, screening libraries, fluorescent dyes, natural products, peptides, ADC linkers, PROTACs, and isotope-labeled compounds for research applications in academic, pharmaceutical, and biotechnology laboratories.
- RNA Research Solutions Complete mRNA research portfolio including raw materials (IVT reagents, cap analogs, modified nucleotides, RNA purification, RNA-LNP), reporter gene mRNAs (fluorescent labeled, linear, circular, self-amplifying), disease/immune mRNAs, gene editing mRNAs, organelle labeled mRNAs, and custom RNA synthesis services for therapeutic and basic research applications.
- Recombinant Proteins and Antibodies Recombinant proteins including cytokines and other proteins, along with protein assay kits, inhibitory antibodies, primary antibodies, and secondary antibodies for research applications in cell biology, immunology, and biochemistry.
- Bioreagents Cell biology and molecular biology reagents including cell culture products, cell proliferation/apoptosis assays, molecular biology kits (PCR, qPCR, recombination and cloning, reverse transcription, NGS library preparation), organoid culture products, and enzymes for laboratory research workflows.
- Custom Services Custom synthesis services including custom compound library service, custom protein synthesis service, and custom RNA synthesis tailored to specific research requirements of pharmaceutical, biotechnology, and academic customers.
- mRNA Synthesis In vitro transcription of capped mRNA with modified nucleotides and poly(A) tail, producing messenger RNA products for research applications including reporter gene mRNAs, disease and immune mRNAs, gene editing mRNAs, and organelle labeled mRNAs.
- Tyramide Signal Amplification (TSA) Proprietary signal amplification system used for signal amplification of in situ hybridization (ISH), immunohistochemistry (IHC), and immunocytochemistry (ICC) applications to enhance detection sensitivity.
- Phos Binding Reagents Phosphorylation research reagents enabling separation of phosphorylated and non-phosphorylated proteins without the need for phospho-specific antibodies, supporting protein phosphorylation studies.
- Inhibitor Cocktails Protease and phosphatase inhibitor cocktails that protect protein integrity from multiple proteases and phosphatases for various research applications including protein extraction and analysis.
- Cell Counting Kit-8 (CCK-8) A convenient and sensitive kit for cell proliferation assay and cytotoxicity assay used in cell biology and drug screening research.
- Caspase-12 Fluorometric Assay Kit Highly sensitive assay kit for detecting ATAD-dependent caspase-12 activity using fluorometric detection based on cleavage of ATAD-AFC substrate, priced at $1,477.00 for 100 assays with 5-10 day shipping.
- Enhanced Apoptotic DNA Ladder Detection Kit Sensitive kit that detects apoptotic DNA fragmentation within 90 minutes without the need for DNA extraction or columns, using agarose gel electrophoresis with highly sensitive dye, priced at $914.00 for 50 assays.
- Annexin V-PE Apoptosis Detection Kit Live cell apoptosis assay kit that detects phosphatidylserine on cell surface within 10 minutes using a bright orange-red PE fluorescent probe, priced at $502.00 for 25 tests.
- INCB024360 analogue Potent and selective inhibitor of IDO1 (indoleamine 2,3-dioxygenase) with IC50 of 67 nM, used in cancer immunotherapy research, available in multiple catalog sizes starting at $50.00 for 5mg.
- Inauhzin Small molecule SIRT1 inhibitor with IC50 of 0.7-2 μM that activates p53 and suppresses tumor growth, available in multiple sizes starting at $30.00 evaluation sample.
- Imatinib Mesylate (STI571) Multi-target tyrosine kinase inhibitor of v-Abl, c-Kit, and PDGFR with IC50 values of 600 nM, 100 nM, and 100 nM respectively, available in multiple sizes starting at $50.00 for 100mg.
Quantifiable outcome
- Fast assay protocols ranging from 10 minutes to 90 minutes
- +1 more outcomes
Companies that use APExBIO Technology
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
APExBIO Technology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
APExBIO Technology partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- VWR InternationalcoreVWR serves as a laboratory supply distribution partner for APExBIO products. The partnership allows customers to order APExBIO products through VWR's extensive laboratory supply distribution network, with promotional incentives such as free samples offered to drive customer acquisition.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
APExBIO Technology competitors and assessment
Company assessmentDirect peers
- MedChemExpress (MCE): Direct peer and arguably the most aggressive direct competitor; MCE sells a similarly broad catalog of signaling pathway inhibitors, kinase inhibitors, natural products, peptides, and bioactive compound libraries, with overlapping price points and SKU coverage aimed at academic and pharma research customers.
- Selleck Chemicals: Direct peer focused on small molecule inhibitors and compound libraries covering kinase, apoptosis, epigenetics, and other signaling pathways, selling into the same academic and pharmaceutical research buyer base as APExBIO with overlapping catalog and similar e-commerce-led GTM.
- Tocris Bioscience (Bio-Techne): Direct peer supplying high-purity small molecules, peptides, and bioactive compounds for neuroscience, signaling pathway, and cell biology research; comparable product categories, customer types, and catalog breadth, now operating with Bio-Techne's broader commercial infrastructure.
- Cayman Chemical: Direct peer offering biochemicals, assay kits, antibodies, proteins, and specialty reagents for life science research; overlapping presence in assay kits, apoptosis detection, and signaling pathway compounds makes it a comparable independent reagent supplier with similar scale.
- Cell Signaling Technology (CST): Direct peer in signaling pathway reagents, antibodies, and assay kits, particularly across apoptosis, kinase, and cell biology applications where APExBIO's bioactive compound and assay kit offerings overlap; comparable academic and pharma research customer base.
Broad incumbents
- Bio-Techne: Broad incumbent parent of Tocris, R&D Systems, and ProteinSimple, offering proteins, antibodies, ELISA kits, and small molecules across the same research workflow APExBIO serves; overlaps in catalog but at much greater scale and with deeper commercial reach.
- Abcam (Danaher): Broad incumbent supplying primary antibodies, secondary antibodies, proteins, and assay kits to research customers; direct overlap with APExBIO's recombinant proteins and antibodies product lines and shared e-commerce-led distribution model.
- Thermo Fisher Scientific: Broad incumbent operating the Invitrogen, Gibco, and Thermo Scientific reagent brands; overlaps with APExBIO across molecular biology kits, cell culture reagents, antibodies, and proteins, and competes for the same academic and biopharma research budgets at much greater scale.
- Sigma-Aldrich (Merck KGaA / MilliporeSigma): Broad incumbent and the largest research chemical and biochemical supplier globally; competes with APExBIO's bioactive compound catalog and assay reagents, and is a default catalog for many of the same academic and pharma research customers.
Regional players
- GeneTex: Direct competitor in research antibodies and a growing presence in assay kits and small molecule reagents, with strong penetration in academic research and complementary catalog coverage where APExBIO is sold; serves overlapping customer segments via e-commerce.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks7 records
Key highlights7 records
Customer concentration
APExBIO Technology social profiles
Digital presenceAPExBIO Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
APExBIO Technology leadership team
Management profileNumber of profiles
Profiles1 record
APExBIO Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
APExBIO Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about APExBIO Technology
What does APExBIO Technology do?
APExBIO Technology manufactures and distributes life sciences research biochemicals, including bioactive compounds (signaling pathway inhibitors, screening libraries, fluorescent dyes, PROTACs, ADC linkers, peptides), RNA research solutions (mRNA synthesis products, IVT reagents, cap analogs, reporter gene mRNAs), recombinant proteins and antibodies, assay kits, molecular biology kits, and bioreagents. The company also offers custom synthesis services for compound libraries, proteins, and RNA tailored to specific research requirements.
Is APExBIO Technology a public or private company?
APExBIO Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was APExBIO Technology founded?
APExBIO Technology was founded in 2013. It employs 51 to 100 people.
Where is APExBIO Technology based?
APExBIO Technology is headquartered in Houston, United States, in the North America region.
How does APExBIO Technology make money?
Three revenue lines are on record. Product Sales (E-commerce) is the primary driver. The others are custom Synthesis Services and distributor Sales.
Who are APExBIO Technology's main competitors?
Direct peers on record are MedChemExpress (MCE), Selleck Chemicals, Tocris Bioscience (Bio-Techne), Cayman Chemical and Cell Signaling Technology (CST). Broad incumbents are Bio-Techne, Abcam (Danaher), Thermo Fisher Scientific and Sigma-Aldrich (Merck KGaA / MilliporeSigma). GeneTex is listed as a regional player.
Does APExBIO Technology have an API?
No public API is recorded for APExBIO Technology.
What industry is APExBIO Technology in?
APExBIO Technology's product category is Life Sciences Research Reagents. Its primary akta.pro industry code is HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA), with a secondary code of HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 325411 and its SIC code is 2833.